Is Eli Lilly and Company overvalued?

Eli Lilly and Company (LLY) looks overvalued — trading about 51% above its fair value.

Overvalued

Price

$1183.72

Fair value

$580.61

Current P/E

51.6

Normal P/E

25.3

Market cap

$1.11T

Dividend yield

0.6%

Return on equity

92.6%

Sector

Healthcare

Fair value compares LLY's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks